Home › NDC Lookup › RxCUI directory › RxCUI 1364496

Lomitapide 5 MG Oral Capsule — RxCUI 1364496

RxNorm drug concept · Semantic clinical drug
RxCUI 1364496 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1364496
Official nameLomitapide 5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslomitapide (as lomitapide mesylate) 5 MG Oral Capsule
FDA products mapped7
Package NDCs mapped7
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lomitapide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Juxtapid is specifically for a rare inherited condition called homozygous familial hypercholesterolemia, or HoFH, where LDL cholesterol is dangerously high from birth because of a...
  • What exactly is Juxtapid used for, and is it for everyone with high cholesterol?
  • You take Juxtapid as a capsule once a day, with a full glass of water, at least 2 hours after your evening meal — not with food. Taking it with or close to a meal tends to make sto...
  • How and when should I take Juxtapid each day?
📖 Read our full Lomitapide guide →

🕸️ Concept Web — How Lomitapide 5 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lomitapide 5 MG Oral Capsule RxCUI 1364496

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lomitapide 1364479
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Juxtapid 1364485
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lomitapide Oral Capsule 1364483
    • Lomitapide Oral Product 1364481
    • Lomitapide Pill 1364482
    • Lomitapide Oral Capsule [Juxtapid] 1364487
    • Juxtapid Oral Product 1364488
    • Juxtapid Pill 1364489
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lomitapide 5 MG SCDC · 1364495
  • Lomitapide Oral Capsule SCDF · 1364483
  • Lomitapide Oral Product SCDG · 1364481
  • Lomitapide Pill SCDG · 1364482

Brand-Name Concepts

  • Lomitapide 5 MG Oral Capsule [Juxtapid] SBD · 1364498
  • Lomitapide 5 MG [Juxtapid] SBDC · 1364497
  • Lomitapide Oral Capsule [Juxtapid] SBDF · 1364487
  • Juxtapid Oral Product SBDG · 1364488
  • Juxtapid Pill SBDG · 1364489
  • Juxtapid BN · 1364485

📦 FDA Products & Package NDCs

7 products · 7 package NDCs
7 package NDCs map to RxCUI 1364496 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10122-0402-28 28 CAPSULE in 1 BOTTLE (10122-402-28) Juxtapid Chiesi USA, Inc. 2026-02-25
10122-0405-28 28 CAPSULE in 1 BOTTLE (10122-405-28) Juxtapid Chiesi USA, Inc. 2013-01-28
10122-0410-28 28 CAPSULE in 1 BOTTLE (10122-410-28) Juxtapid Chiesi USA, Inc. 2013-01-28
10122-0420-28 28 CAPSULE in 1 BOTTLE (10122-420-28) Juxtapid Chiesi USA, Inc. 2013-01-28
10122-0430-28 28 CAPSULE in 1 BOTTLE (10122-430-28) Juxtapid Chiesi USA, Inc. 2015-06-22
76431-0110-01 28 CAPSULE in 1 BOTTLE (76431-110-01) Juxtapid Amryt Pharmaceuticals DAC 2013-01-28
76431-0120-01 28 CAPSULE in 1 BOTTLE (76431-120-01) Juxtapid Amryt Pharmaceuticals DAC 2013-01-28
Observed labelers: Chiesi USA, Inc. (5) · Amryt Pharmaceuticals DAC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.